Congress trades

AngioDynamics, Inc. (ANGO)

NASDAQ · Healthcare · 5 congress trades · last filed 1 year ago

5
Congress disclosures shown
28d
Median delay on the congress disclosures
of the 45 day limit
2 buys·3 sells
Purchases and sales in the disclosures shown
Get a push when a member of Congress trades ANGO.

Free on iOS and Android.

About AngioDynamics, Inc.

from the company's filings and listing, as of Oct 25, 2026
Exchange
NASDAQ
Sector
Healthcare
Industry
Medical - Instruments & Supplies
Chief executive
James C. Clemmer
Employees
632
Listed since
Jun 1, 2004
Market value
$520.0M
Price to earnings (12 mo)
-
Net income per share, as reported (12 mo)
-$0.78
Dividend yield
-

www.angiodynamics.com

Earnings

6 reported quarters · next on Jan 6, 2027
QuarterEPSEPS expectedRevenueRevenue expectedResult
Q1 FY2027reported Oct 8, 2026-$0.04-$0.11$80.9M$80.5MEPS beatRevenue in line
Q4 FY2026reported Jul 14, 2026-$0.07-$0.11$86.6M$80.2MEPS beatRevenue beat
Q3 FY2026reported Apr 2, 2026-$0.07-$0.11$78.4M$76.8MEPS beatRevenue beat
Q2 FY2026reported Jan 6, 2026-$0.15-$0.10$79.4M$76.4MEPS miss, GAAPRevenue beat
Q1 FY2026reported Oct 2, 2025-$0.10-$0.14$75.7M$76.3MEPS beatRevenue in line
Q4 FY2025reported Jul 15, 2025-$0.03-$0.13$80.2M$74.3MEPS beatRevenue beat

Actual against the consensus estimate at the time. A flag marks a beat or a miss of more than 1.5% either way; inside that band the quarter is in line. A flag marked GAAP compares a GAAP figure the company reported with an adjusted consensus, two different measures, so a one-time gain or charge can move it either way. A flag reads n/a only when a number is missing. Quarterly EPS is the figure set against the consensus, usually adjusted, so the quarters need not add up to the 12-month net income per share above. An estimate is a forecast made by analysts, not a company target.

Executive pay

as filed for fiscal 2026 · proxy filed Oct 8, 2026
ExecutiveSalaryStock awardsOtherTotal
James C. ClemmerPresident, CEO$828K$3.7M$1.5M$6.1M
Stephen A. TrowbridgeEVP, CFO$471K$1.6M$634K$2.7M
Laura PiccininiSVP & GM, Cardiovascular and International$471K$580K$558K$1.6M
Lawrence T. WeissSVP, Chief Legal Officer & Corporate Secretary$439K$553K$502K$1.5M
Warren NighanSVP & GM, Global Supply Chain, Quality and Regulatory Affairs$416K$525K$490K$1.4M

The summary compensation table from the proxy statement for fiscal 2026, with titles as filed then. Executives who have since left are not shown. Read the filing

Institutional holders

13F positions as of Jun 30, 2026
HolderValueSharesShares vs prior qtr% of shares out
BlackRock, Inc.$49.5M3,803,232+3.2%9.16%
Point72 Asset Management, L.P.Steve Cohen$39.8M3,062,517-3.7%7.37%
Systematic Financial Management LP$34.3M2,640,214+7.6%6.36%
Armistice Capital, LLC$28.6M2,198,000+17.6%5.29%
Royce & Associates LP$25.6M1,969,835+28.8%4.74%
Broadfin Holdings LLC$23.7M1,818,533-12.1%4.38%
Vanguard Capital Management LLC$22.0M1,694,716-1.9%4.08%
Weber Capital Management LLC$17.6M1,356,602-1.2%3.27%
Nuveen, LLC$15.6M1,199,358-1.4%2.89%
Geode Capital Management, LLC$13.3M1,020,658+3.6%2.46%
Dimensional Fund Advisors LP$12.6M969,497+2.2%2.33%
State Street Corp$12.5M958,167-28.2%2.30%

A 13F reports long US equity positions and is filed within 45 days of the quarter end, so these are positions as they stood on Jun 30, 2026. For a manager's whole book see the fund directory. What a 13F covers and leaves out is explained in our guide to Form 13F.

Know when the next ANGO filing is reported.

GetSignal watches Form 4 and STOCK Act filings and pushes each one to your phone as it is published, with the history behind it. Free on iOS and Android.

Congress trades in ANGO

5 disclosures of 5 on record · median 28d of the 45 allowed

Since the trade: the stock's move from the trade date to the latest close we hold (figures as of Oct 24, 2026), not the member's result. Not investment advice.

MemberTypeActionAmount disclosedStock since the tradeTrade dateDisclosedDelay
Debbie Wasserman SchultzDependent childStockSale$2,000.00as listed, not a band+4.6%After the saleS&P 500 +13.2% · -8.6 pts vs S&P 500Oct 20, 2025Oct 24, 20254d
Debbie Wasserman SchultzDependent childStockPurchase$1,001 - $15,000+26.4%S&P 500 +23.2% · +3.2 pts vs S&P 500Jun 27, 2025Jul 25, 202528d
Debbie Wasserman SchultzStockSale$1,001 - $15,000+43.8%After the saleS&P 500 +21.8% · +22.0 pts vs S&P 500Jul 16, 2025Jul 25, 20259d
Debbie Wasserman SchultzDependent childStockSale$1,001 - $15,000-23.6%After the saleS&P 500 +255.4% · -279.0 pts vs S&P 500Nov 8, 2016Dec 25, 201647d
Debbie Wasserman SchultzDependent childStockPurchase$1,001 - $15,000-0.4%S&P 500 +263.8% · -264.2 pts vs S&P 500Apr 27, 2016Jul 6, 201670d

Since the trade is an estimate, set beside the S&P 500 over the same window, with the gap between the two in percentage points. The filing carries a band, not a fill, and a sale keeps the stock's sign, so a positive figure after a sale means the stock kept rising after it. An option row carries the underlying stock's move. A row marked n/a is one we hold no figure for.

A delay above 45 days is the gap between the dates on the report; we mark a filing late only after checking it.

Every Congress trade in ANGO, filterable by party, chamber, type and account.

Questions

Which members of Congress have traded ANGO?

Debbie Wasserman Schultz disclosed ANGO transactions in the filings shown here.

How quickly are ANGO trades disclosed?

Congressional disclosures took a median of 28 days, against the 45 the STOCK Act allows.

How to read a STOCK Act filing

WHAT THE FILING ACTUALLY SAYS

$A range, not an amount. Members disclose a band such as $1,001 to $15,000. The band is the filing, and we do not narrow it.
45Up to 45 days after the trade, lawfully. The delay column counts calendar days from the transaction to its publication. Inside 45 days is within the law.
OPAn option names the underlying. A contract on a company is described using that company's name, so it can read like a share purchase. Those rows say otherwise.

Congress rows disclose a value range rather than an exact amount, and the STOCK Act allows up to 45 days to report. Full sourcing and the limits of this data are on the methodology page. A filing is a record of a transaction, not a signal, and nothing here is investment advice.

Data as of Oct 26, 2026.

Related companies

traded by the same members, or also in Healthcare

See every company we track